ENYO Pharma is a clinical-stage biopharmaceutical company that develops therapeutics for patients with impaired kidney function. Its lead compound, Vonafexor, is a small molecule…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Enyo Pharma →Already a subscriber? Sign in
Xcout Intel tracks Enyo Pharma continuously — this profile deepens as new filings, funding, people and hiring data arrive.